Tg Therapeutics TGTX
NASDAQ TGTX
$55.78 -0.41 (-0.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Total Non-Current Liabilities (2010 - 2024)

Updated

Tg Therapeutics (TGTX) reported Total Non-Current Liabilities of $211.85 million for Q1 2024, up 25.8% from $168.35 million a year earlier and up 26.4% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Total Non-Current Liabilities (2010 - 2024) Analysis & Trends

At the end of FY2023, Tg Therapeutics posted Total Non-Current Liabilities of $167.67 million, up 25.7% from FY2022.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 32.4% (FY2018 to FY2023).
  • By year, Total Non-Current Liabilities came in at $133.36 million in FY2022 (-5.2%), $140.64 million in FY2021 (+34.9%), $104.24 million in FY2020 (-14.7%) and $122.27 million in FY2019 (+196.6%).
  • The Q1 2024 figure ranks as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2010.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last five quarters, with growth averaging 26.4% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q4 2019 (growth of 196.6%); the low point was Q4 2020 (a decline of 14.7%).
  • Per Business Quant data, the three quarters before Q1 2024 came in at $167.67 million (Q4 2023), $164.83 million (Q3 2023) and $178.88 million (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 211.85 Mn
Dec 31, 2023 167.67 Mn
Sep 30, 2023 164.83 Mn
Jun 30, 2023 178.88 Mn
Mar 31, 2023 168.35 Mn
Dec 31, 2022 133.36 Mn
Sep 30, 2022 115.73 Mn
Jun 30, 2022 120.90 Mn
Mar 31, 2022 130.86 Mn
Dec 31, 2021 140.64 Mn
Sep 30, 2021 96.28 Mn
Jun 30, 2021 96.33 Mn
Mar 31, 2021 101.42 Mn
Dec 31, 2020 104.24 Mn
Sep 30, 2020 101.09 Mn
Jun 30, 2020 98.24 Mn
Mar 31, 2020 101.03 Mn
Dec 31, 2019 122.27 Mn
Sep 30, 2019 116.96 Mn
Jun 30, 2019 91.18 Mn
API Access

Tg Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TGTX&period=max&api_key=YOUR_API_KEY